Global Sexually Transmitted Diseases Diagnostics Market Growth (Status and Outlook) 2026-2032
The global Sexually Transmitted Diseases Diagnostics market size is predicted to grow from US$ 4596 million in 2025 to US$ 7293 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.
Sexually Transmitted Diseases (STDs) Diagnostics refer to the medical tests and procedures used to detect infections transmitted through sexual contact. These diagnostics encompass a variety of methods, including laboratory tests such as blood tests, urine tests, swabs, and culture tests, as well as rapid diagnostic tests and molecular techniques like polymerase chain reaction (PCR). The purpose of these diagnostics is to identify the presence of pathogens like bacteria, viruses, or parasites responsible for STDs, enabling timely and accurate diagnosis, which is essential for effective treatment and prevention of further transmission.
United States market for Sexually Transmitted Diseases Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Sexually Transmitted Diseases Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Sexually Transmitted Diseases Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Sexually Transmitted Diseases Diagnostics players cover Abbott, Thermo Fisher Scientific, CERTEST BIOTEC, OPERON, Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Sexually Transmitted Diseases Diagnostics Industry Forecast” looks at past sales and reviews total world Sexually Transmitted Diseases Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Sexually Transmitted Diseases Diagnostics sales for 2026 through 2032. With Sexually Transmitted Diseases Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sexually Transmitted Diseases Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Sexually Transmitted Diseases Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sexually Transmitted Diseases Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sexually Transmitted Diseases Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sexually Transmitted Diseases Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sexually Transmitted Diseases Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Sexually Transmitted Diseases Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Sexually Transmitted Diseases (STDs) Diagnostics refer to the medical tests and procedures used to detect infections transmitted through sexual contact. These diagnostics encompass a variety of methods, including laboratory tests such as blood tests, urine tests, swabs, and culture tests, as well as rapid diagnostic tests and molecular techniques like polymerase chain reaction (PCR). The purpose of these diagnostics is to identify the presence of pathogens like bacteria, viruses, or parasites responsible for STDs, enabling timely and accurate diagnosis, which is essential for effective treatment and prevention of further transmission.
United States market for Sexually Transmitted Diseases Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Sexually Transmitted Diseases Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Sexually Transmitted Diseases Diagnostics is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Sexually Transmitted Diseases Diagnostics players cover Abbott, Thermo Fisher Scientific, CERTEST BIOTEC, OPERON, Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Sexually Transmitted Diseases Diagnostics Industry Forecast” looks at past sales and reviews total world Sexually Transmitted Diseases Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Sexually Transmitted Diseases Diagnostics sales for 2026 through 2032. With Sexually Transmitted Diseases Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sexually Transmitted Diseases Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Sexually Transmitted Diseases Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sexually Transmitted Diseases Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sexually Transmitted Diseases Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sexually Transmitted Diseases Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sexually Transmitted Diseases Diagnostics.
This report presents a comprehensive overview, market shares, and growth opportunities of Sexually Transmitted Diseases Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cultural and Isolated Organisms
- Molecular Test
- Immunology Assay
- Other
- Gonorrhea
- Syphilis
- Chlamydia
- Herpes Simplex Virus
- Human Papillomavirus
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- Thermo Fisher Scientific
- CERTEST BIOTEC
- OPERON
- Roche
- Bio-Rad laboratories
- Qaigen
- Diasorin SPA
- MedMira
- Hologic
- Cepheid
- BioMeriuex
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sexually Transmitted Diseases Diagnostics Market Size (2021-2032)
2.1.2 Sexually Transmitted Diseases Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Sexually Transmitted Diseases Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Sexually Transmitted Diseases Diagnostics Segment by Type
2.2.1 Cultural and Isolated Organisms
2.2.2 Molecular Test
2.2.3 Immunology Assay
2.2.4 Other
2.2.5 Sexually Transmitted Diseases Diagnostics Market Size by Type
2.2.5.1 Sexually Transmitted Diseases Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Sexually Transmitted Diseases Diagnostics Segment by Application
2.3.1 Gonorrhea
2.3.2 Syphilis
2.3.3 Chlamydia
2.3.4 Herpes Simplex Virus
2.3.5 Human Papillomavirus
2.3.6 Others
2.3.7 Sexually Transmitted Diseases Diagnostics Market Size by Application
2.3.7.1 Sexually Transmitted Diseases Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.7.2 Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
3 SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Sexually Transmitted Diseases Diagnostics Market Size Market Share by Player
3.1.1 Global Sexually Transmitted Diseases Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Sexually Transmitted Diseases Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS BY REGION
4.1 Sexually Transmitted Diseases Diagnostics Market Size by Region (2021-2026)
4.2 Global Sexually Transmitted Diseases Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sexually Transmitted Diseases Diagnostics Market Size Growth (2021-2026)
4.4 APAC Sexually Transmitted Diseases Diagnostics Market Size Growth (2021-2026)
4.5 Europe Sexually Transmitted Diseases Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Sexually Transmitted Diseases Diagnostics Market Size by Country (2021-2026)
5.2 Americas Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026)
5.3 Americas Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sexually Transmitted Diseases Diagnostics Market Size by Region (2021-2026)
6.2 APAC Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026)
6.3 APAC Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (2021-2026)
7.2 Europe Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026)
7.3 Europe Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sexually Transmitted Diseases Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET FORECAST
10.1 Global Sexually Transmitted Diseases Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Sexually Transmitted Diseases Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Sexually Transmitted Diseases Diagnostics Forecast
10.1.3 APAC Sexually Transmitted Diseases Diagnostics Forecast
10.1.4 Europe Sexually Transmitted Diseases Diagnostics Forecast
10.1.5 Middle East & Africa Sexually Transmitted Diseases Diagnostics Forecast
10.2 Americas Sexually Transmitted Diseases Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Sexually Transmitted Diseases Diagnostics Forecast
10.2.2 Canada Market Sexually Transmitted Diseases Diagnostics Forecast
10.2.3 Mexico Market Sexually Transmitted Diseases Diagnostics Forecast
10.2.4 Brazil Market Sexually Transmitted Diseases Diagnostics Forecast
10.3 APAC Sexually Transmitted Diseases Diagnostics Forecast by Region (2027-2032)
10.3.1 China Sexually Transmitted Diseases Diagnostics Market Forecast
10.3.2 Japan Market Sexually Transmitted Diseases Diagnostics Forecast
10.3.3 Korea Market Sexually Transmitted Diseases Diagnostics Forecast
10.3.4 Southeast Asia Market Sexually Transmitted Diseases Diagnostics Forecast
10.3.5 India Market Sexually Transmitted Diseases Diagnostics Forecast
10.3.6 Australia Market Sexually Transmitted Diseases Diagnostics Forecast
10.4 Europe Sexually Transmitted Diseases Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Sexually Transmitted Diseases Diagnostics Forecast
10.4.2 France Market Sexually Transmitted Diseases Diagnostics Forecast
10.4.3 UK Market Sexually Transmitted Diseases Diagnostics Forecast
10.4.4 Italy Market Sexually Transmitted Diseases Diagnostics Forecast
10.4.5 Russia Market Sexually Transmitted Diseases Diagnostics Forecast
10.5 Middle East & Africa Sexually Transmitted Diseases Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Sexually Transmitted Diseases Diagnostics Forecast
10.5.2 South Africa Market Sexually Transmitted Diseases Diagnostics Forecast
10.5.3 Israel Market Sexually Transmitted Diseases Diagnostics Forecast
10.5.4 Turkey Market Sexually Transmitted Diseases Diagnostics Forecast
10.6 Global Sexually Transmitted Diseases Diagnostics Forecast by Type (2027-2032)
10.7 Global Sexually Transmitted Diseases Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Sexually Transmitted Diseases Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Sexually Transmitted Diseases Diagnostics Product Offered
11.1.3 Abbott Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Product Offered
11.2.3 Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 CERTEST BIOTEC
11.3.1 CERTEST BIOTEC Company Information
11.3.2 CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Product Offered
11.3.3 CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 CERTEST BIOTEC Main Business Overview
11.3.5 CERTEST BIOTEC Latest Developments
11.4 OPERON
11.4.1 OPERON Company Information
11.4.2 OPERON Sexually Transmitted Diseases Diagnostics Product Offered
11.4.3 OPERON Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 OPERON Main Business Overview
11.4.5 OPERON Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Sexually Transmitted Diseases Diagnostics Product Offered
11.5.3 Roche Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Bio-Rad laboratories
11.6.1 Bio-Rad laboratories Company Information
11.6.2 Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Product Offered
11.6.3 Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bio-Rad laboratories Main Business Overview
11.6.5 Bio-Rad laboratories Latest Developments
11.7 Qaigen
11.7.1 Qaigen Company Information
11.7.2 Qaigen Sexually Transmitted Diseases Diagnostics Product Offered
11.7.3 Qaigen Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Qaigen Main Business Overview
11.7.5 Qaigen Latest Developments
11.8 Diasorin SPA
11.8.1 Diasorin SPA Company Information
11.8.2 Diasorin SPA Sexually Transmitted Diseases Diagnostics Product Offered
11.8.3 Diasorin SPA Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Diasorin SPA Main Business Overview
11.8.5 Diasorin SPA Latest Developments
11.9 MedMira
11.9.1 MedMira Company Information
11.9.2 MedMira Sexually Transmitted Diseases Diagnostics Product Offered
11.9.3 MedMira Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 MedMira Main Business Overview
11.9.5 MedMira Latest Developments
11.10 Hologic
11.10.1 Hologic Company Information
11.10.2 Hologic Sexually Transmitted Diseases Diagnostics Product Offered
11.10.3 Hologic Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Hologic Main Business Overview
11.10.5 Hologic Latest Developments
11.11 Cepheid
11.11.1 Cepheid Company Information
11.11.2 Cepheid Sexually Transmitted Diseases Diagnostics Product Offered
11.11.3 Cepheid Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cepheid Main Business Overview
11.11.5 Cepheid Latest Developments
11.12 BioMeriuex
11.12.1 BioMeriuex Company Information
11.12.2 BioMeriuex Sexually Transmitted Diseases Diagnostics Product Offered
11.12.3 BioMeriuex Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 BioMeriuex Main Business Overview
11.12.5 BioMeriuex Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sexually Transmitted Diseases Diagnostics Market Size (2021-2032)
2.1.2 Sexually Transmitted Diseases Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Sexually Transmitted Diseases Diagnostics by Country/Region (2021, 2025 & 2032)
2.2 Sexually Transmitted Diseases Diagnostics Segment by Type
2.2.1 Cultural and Isolated Organisms
2.2.2 Molecular Test
2.2.3 Immunology Assay
2.2.4 Other
2.2.5 Sexually Transmitted Diseases Diagnostics Market Size by Type
2.2.5.1 Sexually Transmitted Diseases Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
2.3 Sexually Transmitted Diseases Diagnostics Segment by Application
2.3.1 Gonorrhea
2.3.2 Syphilis
2.3.3 Chlamydia
2.3.4 Herpes Simplex Virus
2.3.5 Human Papillomavirus
2.3.6 Others
2.3.7 Sexually Transmitted Diseases Diagnostics Market Size by Application
2.3.7.1 Sexually Transmitted Diseases Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.7.2 Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
3 SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Sexually Transmitted Diseases Diagnostics Market Size Market Share by Player
3.1.1 Global Sexually Transmitted Diseases Diagnostics Revenue by Player (2021-2026)
3.1.2 Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Player (2021-2026)
3.2 Global Sexually Transmitted Diseases Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS BY REGION
4.1 Sexually Transmitted Diseases Diagnostics Market Size by Region (2021-2026)
4.2 Global Sexually Transmitted Diseases Diagnostics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sexually Transmitted Diseases Diagnostics Market Size Growth (2021-2026)
4.4 APAC Sexually Transmitted Diseases Diagnostics Market Size Growth (2021-2026)
4.5 Europe Sexually Transmitted Diseases Diagnostics Market Size Growth (2021-2026)
4.6 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Sexually Transmitted Diseases Diagnostics Market Size by Country (2021-2026)
5.2 Americas Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026)
5.3 Americas Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sexually Transmitted Diseases Diagnostics Market Size by Region (2021-2026)
6.2 APAC Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026)
6.3 APAC Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (2021-2026)
7.2 Europe Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026)
7.3 Europe Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sexually Transmitted Diseases Diagnostics by Region (2021-2026)
8.2 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026)
8.3 Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SEXUALLY TRANSMITTED DISEASES DIAGNOSTICS MARKET FORECAST
10.1 Global Sexually Transmitted Diseases Diagnostics Forecast by Region (2027-2032)
10.1.1 Global Sexually Transmitted Diseases Diagnostics Forecast by Region (2027-2032)
10.1.2 Americas Sexually Transmitted Diseases Diagnostics Forecast
10.1.3 APAC Sexually Transmitted Diseases Diagnostics Forecast
10.1.4 Europe Sexually Transmitted Diseases Diagnostics Forecast
10.1.5 Middle East & Africa Sexually Transmitted Diseases Diagnostics Forecast
10.2 Americas Sexually Transmitted Diseases Diagnostics Forecast by Country (2027-2032)
10.2.1 United States Market Sexually Transmitted Diseases Diagnostics Forecast
10.2.2 Canada Market Sexually Transmitted Diseases Diagnostics Forecast
10.2.3 Mexico Market Sexually Transmitted Diseases Diagnostics Forecast
10.2.4 Brazil Market Sexually Transmitted Diseases Diagnostics Forecast
10.3 APAC Sexually Transmitted Diseases Diagnostics Forecast by Region (2027-2032)
10.3.1 China Sexually Transmitted Diseases Diagnostics Market Forecast
10.3.2 Japan Market Sexually Transmitted Diseases Diagnostics Forecast
10.3.3 Korea Market Sexually Transmitted Diseases Diagnostics Forecast
10.3.4 Southeast Asia Market Sexually Transmitted Diseases Diagnostics Forecast
10.3.5 India Market Sexually Transmitted Diseases Diagnostics Forecast
10.3.6 Australia Market Sexually Transmitted Diseases Diagnostics Forecast
10.4 Europe Sexually Transmitted Diseases Diagnostics Forecast by Country (2027-2032)
10.4.1 Germany Market Sexually Transmitted Diseases Diagnostics Forecast
10.4.2 France Market Sexually Transmitted Diseases Diagnostics Forecast
10.4.3 UK Market Sexually Transmitted Diseases Diagnostics Forecast
10.4.4 Italy Market Sexually Transmitted Diseases Diagnostics Forecast
10.4.5 Russia Market Sexually Transmitted Diseases Diagnostics Forecast
10.5 Middle East & Africa Sexually Transmitted Diseases Diagnostics Forecast by Region (2027-2032)
10.5.1 Egypt Market Sexually Transmitted Diseases Diagnostics Forecast
10.5.2 South Africa Market Sexually Transmitted Diseases Diagnostics Forecast
10.5.3 Israel Market Sexually Transmitted Diseases Diagnostics Forecast
10.5.4 Turkey Market Sexually Transmitted Diseases Diagnostics Forecast
10.6 Global Sexually Transmitted Diseases Diagnostics Forecast by Type (2027-2032)
10.7 Global Sexually Transmitted Diseases Diagnostics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Sexually Transmitted Diseases Diagnostics Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Sexually Transmitted Diseases Diagnostics Product Offered
11.1.3 Abbott Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Product Offered
11.2.3 Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 CERTEST BIOTEC
11.3.1 CERTEST BIOTEC Company Information
11.3.2 CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Product Offered
11.3.3 CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 CERTEST BIOTEC Main Business Overview
11.3.5 CERTEST BIOTEC Latest Developments
11.4 OPERON
11.4.1 OPERON Company Information
11.4.2 OPERON Sexually Transmitted Diseases Diagnostics Product Offered
11.4.3 OPERON Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 OPERON Main Business Overview
11.4.5 OPERON Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Sexually Transmitted Diseases Diagnostics Product Offered
11.5.3 Roche Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Bio-Rad laboratories
11.6.1 Bio-Rad laboratories Company Information
11.6.2 Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Product Offered
11.6.3 Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bio-Rad laboratories Main Business Overview
11.6.5 Bio-Rad laboratories Latest Developments
11.7 Qaigen
11.7.1 Qaigen Company Information
11.7.2 Qaigen Sexually Transmitted Diseases Diagnostics Product Offered
11.7.3 Qaigen Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Qaigen Main Business Overview
11.7.5 Qaigen Latest Developments
11.8 Diasorin SPA
11.8.1 Diasorin SPA Company Information
11.8.2 Diasorin SPA Sexually Transmitted Diseases Diagnostics Product Offered
11.8.3 Diasorin SPA Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Diasorin SPA Main Business Overview
11.8.5 Diasorin SPA Latest Developments
11.9 MedMira
11.9.1 MedMira Company Information
11.9.2 MedMira Sexually Transmitted Diseases Diagnostics Product Offered
11.9.3 MedMira Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 MedMira Main Business Overview
11.9.5 MedMira Latest Developments
11.10 Hologic
11.10.1 Hologic Company Information
11.10.2 Hologic Sexually Transmitted Diseases Diagnostics Product Offered
11.10.3 Hologic Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Hologic Main Business Overview
11.10.5 Hologic Latest Developments
11.11 Cepheid
11.11.1 Cepheid Company Information
11.11.2 Cepheid Sexually Transmitted Diseases Diagnostics Product Offered
11.11.3 Cepheid Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Cepheid Main Business Overview
11.11.5 Cepheid Latest Developments
11.12 BioMeriuex
11.12.1 BioMeriuex Company Information
11.12.2 BioMeriuex Sexually Transmitted Diseases Diagnostics Product Offered
11.12.3 BioMeriuex Sexually Transmitted Diseases Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 BioMeriuex Main Business Overview
11.12.5 BioMeriuex Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sexually Transmitted Diseases Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Sexually Transmitted Diseases Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cultural and Isolated Organisms
Table 4. Major Players of Molecular Test
Table 5. Major Players of Immunology Assay
Table 6. Major Players of Other
Table 7. Sexually Transmitted Diseases Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
Table 10. Sexually Transmitted Diseases Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
Table 13. Global Sexually Transmitted Diseases Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Player (2021-2026)
Table 15. Sexually Transmitted Diseases Diagnostics Key Players Head office and Products Offered
Table 16. Sexually Transmitted Diseases Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Sexually Transmitted Diseases Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Region (2021-2026)
Table 21. Global Sexually Transmitted Diseases Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Sexually Transmitted Diseases Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Sexually Transmitted Diseases Diagnostics Market Size Market Share by Country (2021-2026)
Table 25. Americas Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
Table 27. Americas Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
Table 29. APAC Sexually Transmitted Diseases Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Sexually Transmitted Diseases Diagnostics Market Size Market Share by Region (2021-2026)
Table 31. APAC Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Sexually Transmitted Diseases Diagnostics Market Size Market Share by Country (2021-2026)
Table 35. Europe Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Sexually Transmitted Diseases Diagnostics
Table 41. Key Market Challenges & Risks of Sexually Transmitted Diseases Diagnostics
Table 42. Key Industry Trends of Sexually Transmitted Diseases Diagnostics
Table 43. Global Sexually Transmitted Diseases Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Sexually Transmitted Diseases Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Sexually Transmitted Diseases Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Abbott Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 48. Abbott Sexually Transmitted Diseases Diagnostics Product Offered
Table 49. Abbott Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Abbott Main Business
Table 51. Abbott Latest Developments
Table 52. Thermo Fisher Scientific Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 53. Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Product Offered
Table 54. Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Thermo Fisher Scientific Main Business
Table 56. Thermo Fisher Scientific Latest Developments
Table 57. CERTEST BIOTEC Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 58. CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Product Offered
Table 59. CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. CERTEST BIOTEC Main Business
Table 61. CERTEST BIOTEC Latest Developments
Table 62. OPERON Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 63. OPERON Sexually Transmitted Diseases Diagnostics Product Offered
Table 64. OPERON Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. OPERON Main Business
Table 66. OPERON Latest Developments
Table 67. Roche Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 68. Roche Sexually Transmitted Diseases Diagnostics Product Offered
Table 69. Roche Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Roche Main Business
Table 71. Roche Latest Developments
Table 72. Bio-Rad laboratories Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 73. Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Product Offered
Table 74. Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Bio-Rad laboratories Main Business
Table 76. Bio-Rad laboratories Latest Developments
Table 77. Qaigen Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 78. Qaigen Sexually Transmitted Diseases Diagnostics Product Offered
Table 79. Qaigen Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Qaigen Main Business
Table 81. Qaigen Latest Developments
Table 82. Diasorin SPA Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 83. Diasorin SPA Sexually Transmitted Diseases Diagnostics Product Offered
Table 84. Diasorin SPA Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Diasorin SPA Main Business
Table 86. Diasorin SPA Latest Developments
Table 87. MedMira Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 88. MedMira Sexually Transmitted Diseases Diagnostics Product Offered
Table 89. MedMira Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. MedMira Main Business
Table 91. MedMira Latest Developments
Table 92. Hologic Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 93. Hologic Sexually Transmitted Diseases Diagnostics Product Offered
Table 94. Hologic Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Hologic Main Business
Table 96. Hologic Latest Developments
Table 97. Cepheid Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 98. Cepheid Sexually Transmitted Diseases Diagnostics Product Offered
Table 99. Cepheid Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Cepheid Main Business
Table 101. Cepheid Latest Developments
Table 102. BioMeriuex Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 103. BioMeriuex Sexually Transmitted Diseases Diagnostics Product Offered
Table 104. BioMeriuex Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. BioMeriuex Main Business
Table 106. BioMeriuex Latest Developments
Table 1. Sexually Transmitted Diseases Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Sexually Transmitted Diseases Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cultural and Isolated Organisms
Table 4. Major Players of Molecular Test
Table 5. Major Players of Immunology Assay
Table 6. Major Players of Other
Table 7. Sexually Transmitted Diseases Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
Table 10. Sexually Transmitted Diseases Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
Table 13. Global Sexually Transmitted Diseases Diagnostics Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Player (2021-2026)
Table 15. Sexually Transmitted Diseases Diagnostics Key Players Head office and Products Offered
Table 16. Sexually Transmitted Diseases Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Sexually Transmitted Diseases Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Region (2021-2026)
Table 21. Global Sexually Transmitted Diseases Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Sexually Transmitted Diseases Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Sexually Transmitted Diseases Diagnostics Market Size Market Share by Country (2021-2026)
Table 25. Americas Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
Table 27. Americas Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
Table 29. APAC Sexually Transmitted Diseases Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Sexually Transmitted Diseases Diagnostics Market Size Market Share by Region (2021-2026)
Table 31. APAC Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Sexually Transmitted Diseases Diagnostics Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Sexually Transmitted Diseases Diagnostics Market Size Market Share by Country (2021-2026)
Table 35. Europe Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Sexually Transmitted Diseases Diagnostics
Table 41. Key Market Challenges & Risks of Sexually Transmitted Diseases Diagnostics
Table 42. Key Industry Trends of Sexually Transmitted Diseases Diagnostics
Table 43. Global Sexually Transmitted Diseases Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Sexually Transmitted Diseases Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Sexually Transmitted Diseases Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Abbott Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 48. Abbott Sexually Transmitted Diseases Diagnostics Product Offered
Table 49. Abbott Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Abbott Main Business
Table 51. Abbott Latest Developments
Table 52. Thermo Fisher Scientific Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 53. Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Product Offered
Table 54. Thermo Fisher Scientific Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Thermo Fisher Scientific Main Business
Table 56. Thermo Fisher Scientific Latest Developments
Table 57. CERTEST BIOTEC Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 58. CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Product Offered
Table 59. CERTEST BIOTEC Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. CERTEST BIOTEC Main Business
Table 61. CERTEST BIOTEC Latest Developments
Table 62. OPERON Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 63. OPERON Sexually Transmitted Diseases Diagnostics Product Offered
Table 64. OPERON Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. OPERON Main Business
Table 66. OPERON Latest Developments
Table 67. Roche Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 68. Roche Sexually Transmitted Diseases Diagnostics Product Offered
Table 69. Roche Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Roche Main Business
Table 71. Roche Latest Developments
Table 72. Bio-Rad laboratories Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 73. Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Product Offered
Table 74. Bio-Rad laboratories Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Bio-Rad laboratories Main Business
Table 76. Bio-Rad laboratories Latest Developments
Table 77. Qaigen Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 78. Qaigen Sexually Transmitted Diseases Diagnostics Product Offered
Table 79. Qaigen Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Qaigen Main Business
Table 81. Qaigen Latest Developments
Table 82. Diasorin SPA Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 83. Diasorin SPA Sexually Transmitted Diseases Diagnostics Product Offered
Table 84. Diasorin SPA Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Diasorin SPA Main Business
Table 86. Diasorin SPA Latest Developments
Table 87. MedMira Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 88. MedMira Sexually Transmitted Diseases Diagnostics Product Offered
Table 89. MedMira Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. MedMira Main Business
Table 91. MedMira Latest Developments
Table 92. Hologic Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 93. Hologic Sexually Transmitted Diseases Diagnostics Product Offered
Table 94. Hologic Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Hologic Main Business
Table 96. Hologic Latest Developments
Table 97. Cepheid Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 98. Cepheid Sexually Transmitted Diseases Diagnostics Product Offered
Table 99. Cepheid Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Cepheid Main Business
Table 101. Cepheid Latest Developments
Table 102. BioMeriuex Details, Company Type, Sexually Transmitted Diseases Diagnostics Area Served and Its Competitors
Table 103. BioMeriuex Sexually Transmitted Diseases Diagnostics Product Offered
Table 104. BioMeriuex Sexually Transmitted Diseases Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. BioMeriuex Main Business
Table 106. BioMeriuex Latest Developments
LIST OF FIGURES
Figure 1. Sexually Transmitted Diseases Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sexually Transmitted Diseases Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Sexually Transmitted Diseases Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Sexually Transmitted Diseases Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Sexually Transmitted Diseases Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type in 2025
Figure 10. Sexually Transmitted Diseases Diagnostics in Gonorrhea
Figure 11. Global Sexually Transmitted Diseases Diagnostics Market: Gonorrhea (2021-2026) & ($ millions)
Figure 12. Sexually Transmitted Diseases Diagnostics in Syphilis
Figure 13. Global Sexually Transmitted Diseases Diagnostics Market: Syphilis (2021-2026) & ($ millions)
Figure 14. Sexually Transmitted Diseases Diagnostics in Chlamydia
Figure 15. Global Sexually Transmitted Diseases Diagnostics Market: Chlamydia (2021-2026) & ($ millions)
Figure 16. Sexually Transmitted Diseases Diagnostics in Herpes Simplex Virus
Figure 17. Global Sexually Transmitted Diseases Diagnostics Market: Herpes Simplex Virus (2021-2026) & ($ millions)
Figure 18. Sexually Transmitted Diseases Diagnostics in Human Papillomavirus
Figure 19. Global Sexually Transmitted Diseases Diagnostics Market: Human Papillomavirus (2021-2026) & ($ millions)
Figure 20. Sexually Transmitted Diseases Diagnostics in Others
Figure 21. Global Sexually Transmitted Diseases Diagnostics Market: Others (2021-2026) & ($ millions)
Figure 22. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application in 2025
Figure 23. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Player in 2025
Figure 24. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Region (2021-2026)
Figure 25. Americas Sexually Transmitted Diseases Diagnostics Market Size 2021-2026 ($ millions)
Figure 26. APAC Sexually Transmitted Diseases Diagnostics Market Size 2021-2026 ($ millions)
Figure 27. Europe Sexually Transmitted Diseases Diagnostics Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size 2021-2026 ($ millions)
Figure 29. Americas Sexually Transmitted Diseases Diagnostics Value Market Share by Country in 2025
Figure 30. United States Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Sexually Transmitted Diseases Diagnostics Market Size Market Share by Region in 2025
Figure 35. APAC Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
Figure 36. APAC Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
Figure 37. China Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 41. India Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Sexually Transmitted Diseases Diagnostics Market Size Market Share by Country in 2025
Figure 44. Europe Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
Figure 45. Europe Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
Figure 46. Germany Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 47. France Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. APAC Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. Europe Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. United States Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Canada Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. Mexico Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Brazil Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. China Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. Japan Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. Korea Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. India Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Australia Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. Germany Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. France Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. UK Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Italy Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 77. Russia Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 78. Egypt Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 79. South Africa Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 80. Israel Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 81. Turkey Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 82. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 1. Sexually Transmitted Diseases Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sexually Transmitted Diseases Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Sexually Transmitted Diseases Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Sexually Transmitted Diseases Diagnostics Sales Market Share by Country/Region (2025)
Figure 8. Sexually Transmitted Diseases Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type in 2025
Figure 10. Sexually Transmitted Diseases Diagnostics in Gonorrhea
Figure 11. Global Sexually Transmitted Diseases Diagnostics Market: Gonorrhea (2021-2026) & ($ millions)
Figure 12. Sexually Transmitted Diseases Diagnostics in Syphilis
Figure 13. Global Sexually Transmitted Diseases Diagnostics Market: Syphilis (2021-2026) & ($ millions)
Figure 14. Sexually Transmitted Diseases Diagnostics in Chlamydia
Figure 15. Global Sexually Transmitted Diseases Diagnostics Market: Chlamydia (2021-2026) & ($ millions)
Figure 16. Sexually Transmitted Diseases Diagnostics in Herpes Simplex Virus
Figure 17. Global Sexually Transmitted Diseases Diagnostics Market: Herpes Simplex Virus (2021-2026) & ($ millions)
Figure 18. Sexually Transmitted Diseases Diagnostics in Human Papillomavirus
Figure 19. Global Sexually Transmitted Diseases Diagnostics Market: Human Papillomavirus (2021-2026) & ($ millions)
Figure 20. Sexually Transmitted Diseases Diagnostics in Others
Figure 21. Global Sexually Transmitted Diseases Diagnostics Market: Others (2021-2026) & ($ millions)
Figure 22. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application in 2025
Figure 23. Global Sexually Transmitted Diseases Diagnostics Revenue Market Share by Player in 2025
Figure 24. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share by Region (2021-2026)
Figure 25. Americas Sexually Transmitted Diseases Diagnostics Market Size 2021-2026 ($ millions)
Figure 26. APAC Sexually Transmitted Diseases Diagnostics Market Size 2021-2026 ($ millions)
Figure 27. Europe Sexually Transmitted Diseases Diagnostics Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size 2021-2026 ($ millions)
Figure 29. Americas Sexually Transmitted Diseases Diagnostics Value Market Share by Country in 2025
Figure 30. United States Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Sexually Transmitted Diseases Diagnostics Market Size Market Share by Region in 2025
Figure 35. APAC Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
Figure 36. APAC Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
Figure 37. China Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 41. India Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Sexually Transmitted Diseases Diagnostics Market Size Market Share by Country in 2025
Figure 44. Europe Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
Figure 45. Europe Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
Figure 46. Germany Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 47. France Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Sexually Transmitted Diseases Diagnostics Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 60. APAC Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 61. Europe Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 63. United States Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 64. Canada Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 65. Mexico Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 66. Brazil Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 67. China Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 68. Japan Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 69. Korea Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 71. India Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 72. Australia Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 73. Germany Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 74. France Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 75. UK Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 76. Italy Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 77. Russia Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 78. Egypt Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 79. South Africa Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 80. Israel Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 81. Turkey Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
Figure 82. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Sexually Transmitted Diseases Diagnostics Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Sexually Transmitted Diseases Diagnostics Market Size 2027-2032 ($ millions)
